Schizophrenia: Building and Fixing Scientific Models

Deniker P . From chlorpromazine to tardive dyskinesia (brief history of neuroleptics). Psychiatric Journal of the University of Ottawa 1989;14:253–9.

Arnt J Skarsfeldt T Hyttel J . Differentiation of classical and novel antipsychotics using animal models. Int Clin Psychopharmacol 1997;12(1 Suppl):S9–S17.

Seeman P . Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 1992;7:261–84.

Murray RM . Neurodevelopmental schizophrenia: The rediscovery of dementia praecox. Br J Psychiatry 1994;165(25 Suppl):6–12.

Weinberger DR Lipska BK . Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: A search for common ground. Schizophr Res 1995;16:87–110.

Bachus SE Kleinman JE . The neuropathology of schizophrenia. J Clin Psychiatry 1996;57(11 Suppl):72–83.

Friston KJ . The disconnection hypothesis. Schizophr Res 1998;30:115–25.

Carlsson A . Neurocircuitries and neurotransmitter interactions in schizophrenia. Int Clin Psychopharmacol 1995;10(3 Suppl):21–8.

Lewis DA Anderson SA . The functional architecture of the prefrontal cortex and schizophrenia. Psychol Med 1995;25:887–94.

Liddle PF . The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br J Psychiatry 1987;151:145–51.

Andreasen NC . Positive vs negative schizophrenia: A critical evaluation. Schizophr Bull 1985;11:380–9.